Covid-19, Pregnancy, and Vaccinations. Article

Holness, Nola A, Powell-Young, Yolanda M, Torres, Elisa et al. (2021). Covid-19, Pregnancy, and Vaccinations. . 32(1), 1-9.

cited authors

  • Holness, Nola A; Powell-Young, Yolanda M; Torres, Elisa; DuBois, Sasha; Giger, Joyce Newman


  • Pregnancy in the presence of COVID-19 increases the risk for illness severity. Data suggest that pregnant women with COVID-19 are more likely to be hospitalized, to be admitted to the intensive care unit, and to require life support. Vaccination is currently considered the most effective preventive intervention against COVID-19 in the United States. However, the unsurprising exclusion of pregnant women as participants in initial COVID-19 vaccine clinical trials has led to a gap in the scientific data regarding the safety profile and subsequent use of COVID-19 vaccine for women who are pregnant. Experts believe current COVID-19 vaccines developed using either mRNA or viral vector vaccine technologies and authorized for emergency use by the United States Food and Drug Administration are unlikely to pose obstetrical or neonatal risks. Still, current vaccination recommendations for women who are pregnant have been both mixed and contradictory. The need to expeditiously identify, collate, and disseminate available vaccine-related safety data is critical to preventing severe illness while also advancing the health and wellness of an underserved high-risk population subgroup.

publication date

  • July 1, 2021


  • COVID-19
  • COVID-19 Vaccines
  • Female
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Pregnant Women
  • SARS-CoV-2
  • United States
  • Vaccination


  • Print

start page

  • 1

end page

  • 9


  • 32


  • 1